chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt screamed for 5 hrs p/vax (cont) was seen by MD & evaluated;
Patient received the COVID-19 Pfizer vaccine on 3/20/2021.  She is under age for this vaccine.  This event was not caught until she came for her second vaccine.  We did not administer the second vaccine.  It has been 20 days since this vaccine was given.  The patient has no complaints or known ill effects from this vaccine given.
Severe chills Fever Indigestion Muscle aches Stomach cramps diarrhea Lethargy Sore arm The chills began at 1:30 a.m.  I was unable to go back to sleep.  As of now, 10/21/2021, 11:51 a.m. I still have a fever, muscle aches, chills, stomach cramps, diarrhea, and lethargy and generally "not feeling well." I took two antacid tablets when the indigestion began about 3 a.m.  I took 2 Excedrin extra strength about 4 a.m.
Sore throat followed by progressive cough and wheezing, symptoms continue to be present for over 1 week.
Approximately 30 minutes after injection, patient said that she was feeling dizzy or light-headed. She slumped, and appeared unconscious for a few seconds. A cold cloth was placed on her forehead and a blood pressure cuff placed on her arm. She appeared better within 5-10 minutes
Itchy, maculopapular rash surrounding both armpits and within both inner, upper arms. Same rash also on left, inner elbow.
The patient called me yesterday asking what to do regard the redness on her arm that is close to the Shingrix shot (1st shot of Shingrix) that she received on 5/24/21. She stated that it feels warm, red, and a bit painful (a few inches in diameter, >3 inches in diameter). I told patient to put cold compresses, take Benadryl 4 times a day, and to see the doctor. I called her back today to double check on her but I had to leave a message. She called me back a few minutes ago and told me that she saw the doctor and she ended up getting an antibiotic shot and oral antibiotics. They are both unsure if the vaccine caused it since the red site was originated about 1.5 inches below the Shingrix shot site. The swelling went down considerably after starting on the antibiotic and it's getting better.
Blistering erythematous rash on trunk along the T4 dermatome, symptoms of fatigue, nausea, and aches. Prescribed Valtrex for seven days.
21 hours  after my 2nd shot I woke up and had Headache, achy all over, tired, a weird stabbing pain in my left ear and left side of neck. that continued all day. Woke up this morning (03/27/2021) and I felt fine, all side effects gone. No treatment
Pt got hives on trunk within 24. Took BENADRYL and ZYRTEC. Got flu like symptoms Day 2 for approximately 1 week.
24 hours after I received the booster vaccine, my labia broke out in painful, blister-like sores. Sores got progressively worse over the next 4 days. Within 72 hours after the sores started, I went to urgent care on 12/13/2021. A doctor examined me and ordered a test for HSV1, HSV2, and VZV. I got retested on 12/15/2021 for the above and also syphilis. All tests negative.
Gave immunocompromised patient a half dose (booster dose); This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Gave immunocompromised patient a half dose (booster dose)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL UNDERDOSE (Gave immunocompromised patient a half dose (booster dose)). At the time of the report, ACCIDENTAL UNDERDOSE (Gave immunocompromised patient a half dose (booster dose)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  The patient had no allergies and had never been tested positive for COVID disease.  The pharmacist reported that they did not know about the patient's immunocompromise situation at the time of vaccination and gave the patient a half booster dose, and wanted to know whether the patient could be given a fourth vaccine shot and at what dosages should they give the patient.
migraines (after 2nd dose); vertigo (after 2nd dose); This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraines (after 2nd dose)) and VERTIGO (vertigo (after 2nd dose)) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia and Arthritis.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (migraines (after 2nd dose)) and VERTIGO (vertigo (after 2nd dose)). At the time of the report, MIGRAINE (migraines (after 2nd dose)) and VERTIGO (vertigo (after 2nd dose)) outcome was unknown.            No concomitant medication were reported.  No treatment information was provided by the reporter.  It was unknown if the IM injection was given into the left or right deltoid.   This case was linked to MOD-2021-402734 (Patient Link).
Pt reports developing redness and itchiness at the site of administration of vaccines: Rt upper arm; 09/04/15 -seen in office 8cm redness, swelling and warmth.
anxiety; dizziness; headache; Injection Site Pain; Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (anxiety), DIZZINESS (dizziness), HEADACHE (headache), INJECTION SITE PAIN (Injection Site Pain) and MYALGIA (Myalgia) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included BENAZEPRIL, HYDRALAZINE, OMEPRAZOLE and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced ANXIETY (anxiety), DIZZINESS (dizziness), HEADACHE (headache), INJECTION SITE PAIN (Injection Site Pain) and MYALGIA (Myalgia). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, ANXIETY (anxiety), DIZZINESS (dizziness), HEADACHE (headache), INJECTION SITE PAIN (Injection Site Pain) and MYALGIA (Myalgia) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided.; Sender's Comments: Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. Headache, injection site pain and myalgia are consistent with the known safety profile of mRNA-1273.
A 73-year-old male, who has a past medical history of asthma, hypertension, TB (tuberculosis), and Type 2 diabetes mellitus, presented to ED due to worsening shortness of air. The patient reported he began to feel short of breath around 09:00 on 12/30/2021. This progressively got worse, prompting the patient's family to call EMS. Constitutional: Positive for chills and fatigue. Negative for activity change, appetite change, diaphoresis, fever and unexpected weight change. HENT: Negative for congestion, ear pain, hearing loss, rhinorrhea, sore throat, trouble swallowing and voice change. Eyes: Negative for discharge and visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for apnea, chest tightness and wheezing. Cardiovascular: Positive for chest pain. Negative for palpitations. He completed Remdesivir while inpatient. Regarding Dexamethasone, it was felt the benefits outweigh the cost as given high risk of a poor outcome from COVID-19 pneumonia. Given elevated procalcitonin and elevated WBC, he was treated for CAP with ceftriaxone and azithro during hospitalization. Discharge Disposition/Condition/Disposition: Home. Condition: Stable (s/sx potential problems absent or manageable).
Pustule type rash on left leg and arms, non-raised, red rash on back, fever of 102.5, lethargy, decreased appeitite.
vomiting/diarrhea;hourly stools T102.7 hosp for IV fluid 12MAR99-13MAR99;
Client received vaccination and then became dizzy and lightheaded. Passed out was sent to ER via EMS
2-3 minutes after administering Varicella SC vaccine - child had profuse nasal discharge, feeling chest discomfort.  Hives face - 125/5 EPI 0.3cc SC right arm 8AM - 3:40PM.  15cc Benadryl PO.
Body aches, headaches, swollen lymph nodes and high body temperature the day after receiving the vaccine. The patient went to the doctor and was diagnosed with having cellulitis.
nausea; headache; fatigue; muscle ache; swelling and joint pain on her knee; swelling and joint pain on her knee; sore left arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of JOINT SWELLING (swelling and joint pain on her knee), PAIN IN EXTREMITY (sore left arm), NAUSEA (nausea), HEADACHE (headache) and FATIGUE (fatigue) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. O25L2UA and 00042714) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Previously administered products included for an unreported indication: SYNVISC ONE (received Synvisc 1 injection on the knee on Sep/Oct 2020.). Concomitant products included MELOXICAM for Back pain, CORTISOL [HYDROCORTISONE] for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2020, the patient experienced PAIN IN EXTREMITY (sore left arm). On 27-Jan-2021, the patient experienced JOINT SWELLING (swelling and joint pain on her knee), NAUSEA (nausea), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (muscle ache) and ARTHRALGIA (swelling and joint pain on her knee). The patient was treated with ACETAMINOPHEN from 27-Jan-2021 to 28-Jan-2021 at an unspecified dose and frequency. On 31-Dec-2020, PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, JOINT SWELLING (swelling and joint pain on her knee), NAUSEA (nausea), HEADACHE (headache), FATIGUE (fatigue), MYALGIA (muscle ache) and ARTHRALGIA (swelling and joint pain on her knee) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Not feeling well; Stomachache; Feeling bad all over; Just wants to sleep it off; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), ABDOMINAL PAIN UPPER (Stomachache), FEELING ABNORMAL (Feeling bad all over), SOMNOLENCE (Just wants to sleep it off) and HEADACHE (Headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 024M70A) for COVID-19 vaccination.     Concurrent medical conditions included Dementia (Early stage of dementia). Concomitant products included DONEPEZIL and VALSARTAN for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced MALAISE (Not feeling well). 17-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomachache), FEELING ABNORMAL (Feeling bad all over), SOMNOLENCE (Just wants to sleep it off) and HEADACHE (Headache). At the time of the report, MALAISE (Not feeling well), ABDOMINAL PAIN UPPER (Stomachache), FEELING ABNORMAL (Feeling bad all over), SOMNOLENCE (Just wants to sleep it off) and HEADACHE (Headache) outcome was unknown. Not Provided          No treatment was provided.   This case was linked to MOD-2021-047769 (Patient Link).
Patient was given a moderna Vaccine on 4/3 and this expired on 4/1. The patient is doing great. No side effects or adverse reactions.
Pain at injection site left arm after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site left arm after 1st dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site left arm after 1st dose). On 02-Mar-2021, VACCINATION SITE PAIN (Pain at injection site left arm after 1st dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient did not receive any treatment medication.   This case was linked to MOD-2021-063821 (Patient Link).
ADMINISTRATION ERROR: NURSE ADMINISTERED FIRST DOSE OF MODERNA LOT #091D21A ON LEFT ARM TO A 13 YRS OLD. INSTEAD OF ADMINISTERING DOSE OF PFIZER WHICH IS INDICATED FOR THE AGE OF THE PATIENT TO THE AUTHORIZATION FOR EMERGENCY USE.
Swelling in the left breast; Tenderness of Breast; Heat Generation on breast; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (Swelling in the left breast), BREAST TENDERNESS (Tenderness of Breast), HEAT EXHAUSTION (Heat Generation on breast) and PYREXIA (Fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 006M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced BREAST SWELLING (Swelling in the left breast), BREAST TENDERNESS (Tenderness of Breast), HEAT EXHAUSTION (Heat Generation on breast) and PYREXIA (Fever). The patient was treated with IBUPROFEN at a dose of 600 milligram and PARACETAMOL (TYLENOL) at a dose of 500 milligram. On 14-Mar-2021, BREAST SWELLING (Swelling in the left breast), BREAST TENDERNESS (Tenderness of Breast), HEAT EXHAUSTION (Heat Generation on breast) and PYREXIA (Fever) had resolved.            Concomitant medication included past natal vitamins.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.
I?ll for 2 days after shot. Felt better until the following week until I had a severe headache and earache. Met with my Dr and could not determine anything at that time. Later that night lost function in the right side of my face. Could not get in to see him so went to other Dr were he said I had Bells Palsy.
Bruising, redness, swelling, heat and a rash the seems to be spreading and is itchy.  Light headed
Information has been received from a physician concerning a 7 year old male who was vaccinated with a dose of varicella virus vaccine live. On 1/25/04 the patient developed breakthrough chicken pox, with the rash onset was 1/25/04. The physician reported that he had a patient report to the office with a chicken pox like rash on 1/27/04. The rash had scabs on his back, stomach, and shoulders. The lesions were crusted over. The quantity was not recorded. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
This spontaneous report was received from a registered pharmacist concerning a female patient of unknown age with no drug reactions or allergies. On an unknown date, about the time when the vaccine was first released to the market, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant therapy was reported. On unknown dates, the patient experienced 5 or 6 episodes of shingles (about 1 episode every year) that involved a recurring bump on the lower back of the patient and viral activity around the eye of the patient. It was reported that the patient was having one of these shingles episodes at the time of reporting (reported as currently, on 08-OCT-2013) (start date unspecified). VZVIP packet was faxed to pharmacist. It was unspecified if the patient sought any medical attention. It was unspecified if any treatment was provided or if any lab tests were performed. The outcome of 5 or 6 episodes of shingles (about 1 episode every year) that involves a recurring bump on the patient's lower back and viral activity around the patient's eye was unknown. The patient was not recovered from the event as the patient was having one of these shingles episodes at the time of reporting. The relatedness for the events was unknown for ZOSTAVAX. Additional information has been requested.
Post vaccines mom reported lethargy and trouble breathing. Brought via ambulance mom stated patient stopped breathing x 2 mins. Pt admitted for 24 hour observation.  Dx possible febrile seizure with postictal state sec fever vs vaccines.
7 days later there is still a soreness and swelling at the injection site. It has reduced but it's still pronounced.
Pt recvd vax & exp redness & swelling @ inject site w/in 24 hrs; reaction abated in 24 hrs;
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided. On 13-JUN-2016, the patient was vaccinated with an improperly stored dose of M-M-R II 0.5 ml injection, lot# L027432, expiration date: 22-JUL-2017, (route and site of administration were not reported). According to the reporter, the vaccine was stored at a temperature of 11.1 degrees Celsius for 1 hour and 36 minutes and also at a temperature of -12.3 degrees Celsius for 1 hour and 33 minutes (excursion dates were not reported). No adverse symptoms were reported. No product quality complain (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
I've had Menopause since May 2020, which is about exactly a year ago. Approximately one moth after getting my first dose of the Pfizer vaccine, I began to have a period (menstruation) for the first time in one year. The period lasted a week. As noted previously, I have not taken any medication before or after taking the vaccine, which is why I suspected that the vaccine was the cause of my sudden menstruation. I was scared of this adverse reaction, which is why I decided not to take a second shot dose of the Pfizer vaccine.
Pt Received Anthrax vaccine 10 Dec 2008, # 3 of 6 shots. Pt found that she was pregnant on 13 Jan 2009. Pt had no reaction to the Vaccine.  Reporting for administrative reasons.
Patient received second dose of Moderna COVID vaccine on 1/15/21, developed headache and fever on 1/16/21 which resolved without treatment within 24 hours.
More than 36 days since first shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 36 days since first shot) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days since first shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 36 days since first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were reported.   Reporter did not allow further contact
frozen shoulder on the left side developed since mid-March, and has worsened over the last 5 months, and is not getting any better.
12/24/20-injection site pain and swelling 12/28/20-Fever (99.3-101), headache, abd pain, nausea, malaise  12/31/20-injection site pain, swelling, redness, itching
I was diagnosed with shingles February 3 after my first shot January 19th. Symptoms started week of January 25th. Today is March 4th and still having nerve pains.
devel tendinitis in lt elbow 72hr p/vax;pt recv cortisone inj by MD;
Patient states that 1 day after vaccination he began experiencing shortness of breath and chest pain upon exertion. He states he works out frequently and was at the gym lifting weights post vaccination and noticed the shortness of breath. Later the same week he also had chest pain accompanying the shortness of breath upon exertion. Both resolved with rest. The symptoms lasted approximately 2 weeks, and have since resolved. The patient did not seek any medical care, but asked about it when he presented for his 2nd dose. Second dose not administered, recommended to consult with PCP before getting 2nd vaccination.
Patient presented to the ED and was subsequently hospitalized for upper GI bleed within 6 weeks of receiving COVID vaccination.